The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease.
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2012
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Janssen
- 16 Mar 2012 Actual patient number changed from 94 to 99 as reported by ClinicalTrials.gov.
- 01 Feb 2010 New trial record